Lisa O’Flynn

1.6k total citations · 1 hit paper
21 papers, 1.2k citations indexed

About

Lisa O’Flynn is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Lisa O’Flynn has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Lisa O’Flynn's work include Mesenchymal stem cell research (14 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Extracellular vesicles in disease (3 papers). Lisa O’Flynn is often cited by papers focused on Mesenchymal stem cell research (14 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Extracellular vesicles in disease (3 papers). Lisa O’Flynn collaborates with scholars based in Ireland, United Kingdom and Netherlands. Lisa O’Flynn's co-authors include Thomas Ritter, Oliver Treacy, Steve Elliman, Frank Barry, Martin J. Hoogduijn, S Witte, Carla C. Baan, Philip N. Newsome, Ana Merino and Timothy O’Brien and has published in prestigious journals such as PLoS ONE, Oncogene and International Journal of Cancer.

In The Last Decade

Lisa O’Flynn

20 papers receiving 1.1k citations

Hit Papers

Immunomodulation By Thera... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells
    2018 375 citations S Witte, Franka Luk et al. Stem Cells profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa O’Flynn Ireland 15 783 388 344 213 139 21 1.2k
Oliver Treacy Ireland 16 671 0.9× 380 1.0× 334 1.0× 188 0.9× 191 1.4× 26 1.1k
Rosa María Pérez Yáñez Spain 14 818 1.0× 391 1.0× 400 1.2× 205 1.0× 197 1.4× 40 1.3k
Attila Szakos Sweden 11 1.0k 1.3× 515 1.3× 353 1.0× 212 1.0× 198 1.4× 20 1.6k
Miyeon Kim South Korea 12 687 0.9× 410 1.1× 331 1.0× 117 0.5× 82 0.6× 23 1.1k
Franka Luk Netherlands 13 927 1.2× 481 1.2× 454 1.3× 271 1.3× 166 1.2× 15 1.4k
Katarina LeBlanc Sweden 16 1.0k 1.3× 471 1.2× 380 1.1× 229 1.1× 261 1.9× 21 1.6k
Paul Lohan Ireland 16 539 0.7× 314 0.8× 266 0.8× 167 0.8× 147 1.1× 18 968
Federico Mosna Italy 16 721 0.9× 477 1.2× 537 1.6× 209 1.0× 207 1.5× 30 1.4k
Sara M. Melief Netherlands 6 664 0.8× 315 0.8× 253 0.7× 218 1.0× 125 0.9× 6 893

Countries citing papers authored by Lisa O’Flynn

Since Specialization
Citations

This map shows the geographic impact of Lisa O’Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa O’Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa O’Flynn more than expected).

Fields of papers citing papers by Lisa O’Flynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa O’Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa O’Flynn. The network helps show where Lisa O’Flynn may publish in the future.

Co-authorship network of co-authors of Lisa O’Flynn

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa O’Flynn. A scholar is included among the top collaborators of Lisa O’Flynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa O’Flynn. Lisa O’Flynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Sullivan, Anne Marie, Louise Gallagher, Gregory A. Johnson, et al.. (2024). Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection system. Molecular Therapy — Methods & Clinical Development. 33(1). 101389–101389. 3 indexed citations
2.
3.
Pappritz, Kathleen, Fengquan Dong, Kapka Miteva, et al.. (2021). Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice. Frontiers in Cardiovascular Medicine. 8. 632728–632728. 4 indexed citations
4.
Pappritz, Kathleen, Oliver Klein, Fengquan Dong, et al.. (2020). MALDI‐IMS as a Tool to Determine the Myocardial Response to Syndecan‐2‐Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy. PROTEOMICS - CLINICAL APPLICATIONS. 15(1). e2000050–e2000050. 6 indexed citations
5.
Watson, Luke, Aideen E. Ryan, Lisa O’Flynn, et al.. (2020). Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot Study. Cells. 9(6). 1394–1394. 3 indexed citations
6.
Horie, Shahd, Claire Masterson, Lisa O’Flynn, et al.. (2020). Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: impact of dose regimen, passage, cryopreservation, and antibiotic therapy. Stem Cell Research & Therapy. 11(1). 116–116. 26 indexed citations
7.
Watson, Luke, Laura Deedigan, Róisín M. Dwyer, et al.. (2020). Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion. International Journal of Cancer. 148(5). 1245–1259. 22 indexed citations
8.
9.
Witte, S, Ana Merino, Sander S. Korevaar, et al.. (2018). Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expansion. Cytotherapy. 20(7). 919–929. 22 indexed citations
10.
Witte, S, Franka Luk, Jesús María Sierra-Párraga, et al.. (2018). Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells. Stem Cells. 36(4). 602–615. 375 indexed citations breakdown →
11.
Witte, S, Ana Merino, Tanja Strini, et al.. (2017). Aging of bone marrow– and umbilical cord–derived mesenchymal stromal cells during expansion. Cytotherapy. 19(7). 798–807. 62 indexed citations
12.
Witte, S, Ana Merino, Marcella Franquesa, et al.. (2017). Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease. Stem Cell Research & Therapy. 8(1). 140–140. 83 indexed citations
13.
Farrell, Eric, Niamh Fahy, Aideen E. Ryan, et al.. (2016). vIL-10-overexpressing human MSCs modulate naïve and activated T lymphocytes following induction of collagenase-induced osteoarthritis. Stem Cell Research & Therapy. 7(1). 74–74. 18 indexed citations
14.
Treacy, Oliver, et al.. (2015). Corneal Immunosuppressive Mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and Their Role in Allograft Rejection. Methods in molecular biology. 1371. 205–214. 14 indexed citations
15.
Treacy, Oliver, Lisa O’Flynn, Aideen E. Ryan, et al.. (2014). Mesenchymal Stem Cell Therapy Promotes Corneal Allograft Survival in Rats by Local and Systemic Immunomodulation. American Journal of Transplantation. 14(9). 2023–2036. 40 indexed citations
16.
Ryan, Aideen E., et al.. (2014). Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis. Oncogene. 34(12). 1563–1574. 48 indexed citations
17.
O’Flynn, Lisa, Oliver Treacy, Aideen E. Ryan, et al.. (2013). Donor Bone Marrow–derived Dendritic Cells Prolong Corneal Allograft Survival and Promote an Intragraft Immunoregulatory Milieu. Molecular Therapy. 21(11). 2102–2112. 10 indexed citations
18.
Ryan, Aideen E., Paul Lohan, Lisa O’Flynn, et al.. (2013). Chondrogenic Differentiation Increases Antidonor Immune Response to Allogeneic Mesenchymal Stem Cell Transplantation. Molecular Therapy. 22(3). 655–667. 82 indexed citations
19.
Treacy, Oliver, Aideen E. Ryan, Lisa O’Flynn, et al.. (2012). Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation. PLoS ONE. 7(8). e42662–e42662. 33 indexed citations
20.
Wilk, Mieszko M., et al.. (2012). Role of Lentivirus-Mediated Overexpression of Programmed Death-Ligand 1 on Corneal Allograft Survival. American Journal of Transplantation. 12(5). 1313–1322. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Treacy Breakdown of academic impact, for papers by Rosa María Pérez Yáñez Breakdown of academic impact, for papers by Attila Szakos Breakdown of academic impact, for papers by Miyeon Kim Breakdown of academic impact, for papers by Franka Luk Breakdown of academic impact, for papers by Katarina LeBlanc Breakdown of academic impact, for papers by Paul Lohan Breakdown of academic impact, for papers by Federico Mosna Breakdown of academic impact, for papers by Sara M. Melief
Rankless by CCL
2026